Skip to main content
logo
Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
5.95
-0.21 (-3.41%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Clinuvel Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
33.9236.1735.6430.620.88
Depreciation & Amortization
0.991.151.090.740.72
Loss (Gain) From Sale of Assets
0.06---0.03
Stock-Based Compensation
2.3426.118.996.12
Provision & Write-off of Bad Debts
-0.15----
Other Operating Activities
3.03-0.420.67-0.210.17
Change in Accounts Receivable
4.16-1.22-4.02-6.01-0.11
Change in Inventory
1.941.81-1.11-7.691.35
Change in Accounts Payable
-0.72.84-0.654.51-1.56
Change in Income Taxes
-7.83-1.3-0.248.817.18
Change in Other Net Operating Assets
0.96-0.870.07-1.41-0.97
Operating Cash Flow
36.9141.137.0536.9139.87
Operating Cash Flow Growth
-10.18%10.91%0.38%-7.42%107.00%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-1.6-0.3-5.58-1.03-0.43
Investment in Securities
-37.52-47.42-23.46-30.82-
Investing Cash Flow
-39.12-47.72-29.03-31.85-0.43

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Repaid
-0.24-0.18-0.35-0.26-0.27
Net Debt Issued (Repaid)
-0.24-0.18-0.35-0.26-0.27
Issuance of Common Stock
0.560.194.16--
Repurchase of Common Stock
-0.56-0.44-4.91--
Common Dividends Paid
-2.51-2.5-2.47-1.98-1.24
Other Financing Activities
-0.01----
Financing Cash Flow
-2.75-2.94-3.57-2.24-1.5

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-1.672.38-1.141.660.88
Net Cash Flow
-6.63-7.183.314.4838.82

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
35.3140.831.4835.8839.44
Free Cash Flow Growth
-13.46%29.61%-12.28%-9.01%114.25%
Free Cash Flow Margin
37.55%42.94%35.70%45.82%60.01%
Free Cash Flow Per Share
0.700.810.620.690.76
Levered Free Cash Flow
25.3929.9123.4532.3333.25
Unlevered Free Cash Flow
25.3929.9126.2334.3334.67

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
23.3615.7315.657.74-
Change in Working Capital
-3.262.2-6.44-3.2211.96
SEC Filings: 10-K · 10-Q